Showing results (2071-2080 of 2,436) with videos related to

Sort By:
Pageof 244
Frontiers in Immunology|May 6, 2026
Real-world incidence of G3-G4 adverse events in patients with advanced renal cell carcinoma receiving immune-combinations (ARON-1)Evelyn L Beas-Lozano, Sarah Scagliarini, Paola I Valdez-Sandoval, et al.
World Journal of Urology|January 24, 2023
Assessment of association between lower ureteric excision technique and oncological outcomes for upper urinary tract urothelial carcinoma: retrospective analysis from the Scottish Renal Cancer ConsortiumJames Peter Blackmur, Etienne Chew, Matthew Trail, et al.
ESMO Open|March 16, 2024
REGOMA-OSS: a large, Italian, multicenter, prospective, observational study evaluating the efficacy and safety of regorafenib in patients with recurrent glioblastomaM Caccese, I Desideri, V Villani, et al.
The Lancet. Microbe|July 27, 2025
Severe acute respiratory syndrome (SARS) mathematical models and disease parameters: a systematic reviewChristian Morgenstern, Thomas Rawson, Isobel Routledge, et al.
Cancer Immunology, Immunotherapy : CII|May 9, 2025
Pembrolizumab plus Lenvatinib in patients with metastatic Renal Cell Carcinoma: real-world evidences from the international ARON- 1 studyCamillo Porta, Francesco Massari, Tarek Taha, et al.
Targeted Oncology|May 5, 2024
Real-World Impact of Upfront Cytoreductive Nephrectomy in Metastatic Non-Clear Cell Renal Cell Carcinoma Treated with First-Line Immunotherapy Combinations or Tyrosine Kinase Inhibitors (A Sub-Analysis from the ARON-1 Retrospective Study)Ondřej Fiala, Sebastiano Buti, Aristotelis Bamias, et al.
Journal of Medicinal Chemistry|July 2, 2015
New Indole Tubulin Assembly Inhibitors Cause Stable Arrest of Mitotic Progression, Enhanced Stimulation of Natural Killer Cell Cytotoxic Activity, and Repression of Hedgehog-Dependent CancerGiuseppe La Regina, Ruoli Bai, Antonio Coluccia, et al.
Developmental Cell|May 6, 2023
A platform for efficient establishment and drug-response profiling of high-grade serous ovarian cancer organoidsWojciech Senkowski, Laura Gall-Mas, Matías Marín Falco, et al.
Scientific Reports|March 15, 2025
Sex as modifier of survival in patients with advanced urothelial cancer treated with pembrolizumabLorena Incorvaia, Sarah Scagliarini, Fernando Sabino Marques Monteiro, et al.
The Oncologist|December 2, 2025
Homologous recombination repair genetic testing variables and diagnostic paths for prostate cancer patients: a multicenter cohort studyLorena Incorvaia, Mattia Puglisi, Marco Maruzzo, et al.
Pageof 244